Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion type Assertion NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_head.
- NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion description "[Human epidermal growth factor receptor 2 (HER2) overexpression is present in approximately 15% of early invasive breast cancers, and is an important predictive and prognostic marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_provenance.
- NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion evidence source_evidence_literature NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_provenance.
- NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion SIO_000772 25488926 NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_provenance.
- NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion wasDerivedFrom befree-2016 NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_provenance.
- NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_assertion wasGeneratedBy ECO_0000203 NP1246323.RA1Jp6_WjUynWlWbFYjXQ7nnwpgc2Br-GY2LoV6_mWxh4130_provenance.